Personalis, Inc. Cash Flow Statement
PSNL / Health Care|9 years of annual SEC 10-K data (FY2017-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 9 fiscal years. All figures from audited SEC 10-K filings.
Personalis, Inc. used $75M in operating cash flow and negative free cash flow of $79M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.22 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$81.3M | -$108.3M | -$65.2M | -$113.3M | -$65.2M | -$19.9M | -$23.6M | -$19.9M | -$23.6M |
| Depreciation & Amortization | $10.0M | $11.3M | $6.0M | $8.4M | $6.0M | $3.1M | $1.2M | $3.1M | $1.2M |
| Operating Cash Flow | -$74.9M | -$56.3M | -$70.8M | -$70.2M | -$70.8M | $5.6M | $290.0K | $5.6M | $290.0K |
| Capital Expenditures | $4.5M | $10.9M | $11.1M | $49.9M | $11.1M | $7.9M | $5.2M | $7.9M | $5.2M |
| Free Cash Flow | -$79.5M | -$67.2M | -$81.9M | -$120.1M | -$81.9M | -$2.3M | -$4.9M | -$2.3M | -$4.9M |
| FCF Margin | -114.1% | -91.4% | -95.8% | -184.7% | -95.8% | -6.0% | -51.8% | -6.0% | - |